Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.76)
# 599
Out of 4,407 analysts
660
Total ratings
47.3%
Success rate
16.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTC Benitec Biopharma | Downgraded: Hold | n/a | $11.16 | - | 2 | Jun 10, 2026 | |
| NTLA Intellia Therapeutics | Rated: Hold | n/a | $12.11 | - | 7 | Jun 10, 2026 | |
| PASG Passage Bio | Downgraded: Hold | n/a | $5.81 | - | 6 | Jun 10, 2026 | |
| NGNE Neurogene | Initiated Coverage: Buy | $69 | $29.10 | +137.11% | 2 | Jun 9, 2026 | |
| TRDA Entrada Therapeutics | Maintained: Buy | $20 → $17 | $6.46 | +163.16% | 3 | Jun 5, 2026 | |
| IRD Opus Genetics | Initiated Coverage: Buy | $16 | $4.04 | +296.04% | 1 | Jun 4, 2026 | |
| RZLT Rezolute | Maintained: Buy | $6 | $4.00 | +50.00% | 4 | Jun 3, 2026 | |
| VYGR Voyager Therapeutics | Maintained: Buy | $22 | $3.50 | +528.57% | 24 | Jun 2, 2026 | |
| DTIL Precision BioSciences | Maintained: Buy | $19 | $6.10 | +211.48% | 16 | May 28, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $32.08 | $8.02 | +299.94% | 2 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $43 | $24.35 | +76.59% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $30.40 | +48.03% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $317.97 | -10.68% | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $39.72 | - | 5 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $1.47 | +376.19% | 3 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $7.14 | +264.15% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $46 → $58 | $24.15 | +140.17% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $39 | $30.72 | +26.95% | 2 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $4.37 | +586.50% | 1 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $95 | $27.57 | +244.58% | 64 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $64 → $92 | $73.28 | +25.55% | 10 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $15.31 | +43.70% | 101 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $5 | $2.78 | +80.18% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $106 | $55.95 | +89.45% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $546 | $444.93 | +22.72% | 7 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $55 | $29.03 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $34.83 | n/a | 1 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $50 | $18.19 | n/a | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $49.80 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $282.85 | n/a | 3 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $24 | $5.71 | n/a | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $2.50 | n/a | 1 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $16 | $0.151 | n/a | 10 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $28.80 | n/a | 14 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $5.87 | n/a | 19 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $29.82 | n/a | 8 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 25.00 | $3.03 | n/a | 7 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $270 → $123 | $28.92 | n/a | 19 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $30 | $12.64 | n/a | 20 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $30.28 | n/a | 19 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.56 | n/a | 20 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $2.06 | n/a | 4 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 | $22.88 | n/a | 10 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $1.90 | n/a | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.05 | n/a | 5 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $3.96 | n/a | 45 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $26 | $59.38 | n/a | 50 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $14.01 | n/a | 15 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $29.46 | n/a | 9 | Aug 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $7 | $82.91 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $1.5 | $2.02 | n/a | 5 | Oct 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.5 → $10 | $11.15 | n/a | 23 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 | $75.14 | n/a | 19 | Oct 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.48 | n/a | 7 | Aug 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $16 | $6.97 | n/a | 13 | Aug 14, 2015 |
Benitec Biopharma
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $11.16
Upside: -
Intellia Therapeutics
Jun 10, 2026
Rated: Hold
Price Target: n/a
Current: $12.11
Upside: -
Passage Bio
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $5.81
Upside: -
Neurogene
Jun 9, 2026
Initiated Coverage: Buy
Price Target: $69
Current: $29.10
Upside: +137.11%
Entrada Therapeutics
Jun 5, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $6.46
Upside: +163.16%
Opus Genetics
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $4.04
Upside: +296.04%
Rezolute
Jun 3, 2026
Maintained: Buy
Price Target: $6
Current: $4.00
Upside: +50.00%
Voyager Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $22
Current: $3.50
Upside: +528.57%
Precision BioSciences
May 28, 2026
Maintained: Buy
Price Target: $19
Current: $6.10
Upside: +211.48%
Satellos Bioscience Inc.
May 19, 2026
Maintained: Buy
Price Target: $32.08
Current: $8.02
Upside: +299.94%
May 8, 2026
Maintained: Buy
Price Target: $52 → $43
Current: $24.35
Upside: +76.59%
May 7, 2026
Maintained: Buy
Price Target: $45
Current: $30.40
Upside: +48.03%
May 4, 2026
Reiterated: Buy
Price Target: $284
Current: $317.97
Upside: -10.68%
Apr 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $39.72
Upside: -
Mar 31, 2026
Maintained: Buy
Price Target: $7
Current: $1.47
Upside: +376.19%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $7.14
Upside: +264.15%
Mar 4, 2026
Rated: Buy
Price Target: $46 → $58
Current: $24.15
Upside: +140.17%
Dec 3, 2025
Maintained: Buy
Price Target: $32 → $39
Current: $30.72
Upside: +26.95%
Oct 15, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $4.37
Upside: +586.50%
Sep 24, 2025
Maintained: Buy
Price Target: $28 → $95
Current: $27.57
Upside: +244.58%
Sep 22, 2025
Maintained: Buy
Price Target: $64 → $92
Current: $73.28
Upside: +25.55%
Sep 15, 2025
Reiterated: Buy
Price Target: $22
Current: $15.31
Upside: +43.70%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $5
Current: $2.78
Upside: +80.18%
Aug 6, 2025
Maintained: Buy
Price Target: $110 → $106
Current: $55.95
Upside: +89.45%
Aug 6, 2025
Maintained: Buy
Price Target: $450 → $546
Current: $444.93
Upside: +22.72%
May 7, 2025
Maintained: Buy
Price Target: $78 → $55
Current: $29.03
Upside: n/a
Apr 30, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $34.83
Upside: n/a
Aug 14, 2024
Maintained: Buy
Price Target: $45 → $50
Current: $18.19
Upside: n/a
Jun 28, 2024
Rated: Hold
Price Target: n/a
Current: $49.80
Upside: n/a
Jun 27, 2022
Downgraded: Hold
Price Target: n/a
Current: $282.85
Upside: n/a
Apr 5, 2022
Maintained: Buy
Price Target: $28 → $24
Current: $5.71
Upside: n/a
Mar 17, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $2.50
Upside: n/a
Jan 6, 2021
Initiated Coverage: Hold
Price Target: $14 → $16
Current: $0.151
Upside: n/a
Sep 3, 2020
Reiterated: Buy
Price Target: $17
Current: $28.80
Upside: n/a
Sep 1, 2020
Maintained: Buy
Price Target: $20
Current: $5.87
Upside: n/a
Aug 31, 2020
Reiterated: Buy
Price Target: $30
Current: $29.82
Upside: n/a
Aug 28, 2020
Reiterated: Buy
Price Target: CHF 25.00
Current: $3.03
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: $270 → $123
Current: $28.92
Upside: n/a
Aug 11, 2020
Maintained: Buy
Price Target: $36 → $30
Current: $12.64
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $13
Current: $30.28
Upside: n/a
Aug 7, 2020
Reiterated: Buy
Price Target: $24
Current: $1.56
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $42
Current: $2.06
Upside: n/a
Aug 6, 2020
Maintained: Buy
Price Target: $54
Current: $22.88
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $49
Current: $1.90
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $25
Current: $4.05
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $40
Current: $3.96
Upside: n/a
May 12, 2020
Reiterated: Hold
Price Target: $32 → $26
Current: $59.38
Upside: n/a
Dec 18, 2019
Maintained: Buy
Price Target: $2
Current: $14.01
Upside: n/a
Aug 1, 2017
Maintained: Hold
Price Target: n/a
Current: $29.46
Upside: n/a
Dec 20, 2016
Initiated Coverage: Sell
Price Target: $7
Current: $82.91
Upside: n/a
Oct 20, 2016
Maintained: Hold
Price Target: $9 → $1.5
Current: $2.02
Upside: n/a
Oct 26, 2015
Initiated Coverage: Buy
Price Target: $7.5 → $10
Current: $11.15
Upside: n/a
Oct 16, 2015
Maintained: Hold
Price Target: $63
Current: $75.14
Upside: n/a
Aug 16, 2015
Maintained: Buy
Price Target: $4
Current: $0.48
Upside: n/a
Aug 14, 2015
Reiterated: Buy
Price Target: $10 → $16
Current: $6.97
Upside: n/a